Iovance Biotherapeutics IOVA

$ 8.51 3.22%

Quarterly report 2024-Q3
added 11-07-2024

Iovance Biotherapeutics Cash and Cash Equivalents 2011-2024 | IOVA

Annual Cash and Cash Equivalents Iovance Biotherapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
115 M	232 M	78.2 M	67.3 M	14 M	82.2 M	145 M	107 M	33.6 M	44.9 M	19.7 M	-	510 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
232 M	510 K	78.3 M

Quarterly Cash and Cash Equivalents Iovance Biotherapeutics

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
164 M	229 M	134 M	115 M	268 M	230 M	543 M	232 M	118 M	108 M	92.4 M	78.2 M	58.6 M	82.8 M	132 M	67.3 M	67.3 M	67.3 M	67.3 M	14 M	14 M	14 M	14 M	82.2 M	82.2 M	82.2 M	82.2 M	145 M	145 M	145 M	145 M	107 M	107 M	107 M	107 M	33.6 M	33.6 M	13.6 M	13.6 M	44.9 M	44.9 M	44.9 M	44.9 M	19.7 M	19.7 M	19.7 M	19.7 M	-	-	15.5 K	-	510 K	510 K	510 K	510 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
543 M	15.5 K	88.5 M